| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI107423 |
| P8608 | Fatcat ID | release_ftm7pmjhmraxfafkl5xbdv5nwu |
| P953 | full work available at URL | https://europepmc.org/articles/PMC333039 |
| https://europepmc.org/articles/PMC333039?pdf=render | ||
| P932 | PMC publication ID | 333039 |
| P698 | PubMed publication ID | 4727463 |
| P2093 | author name string | G. L. Robertson | |
| T. Sinha | |||
| S. Athar | |||
| E. A. Mahr | |||
| P2860 | cites work | Increased plasma arginine vasopressin in clinical adrenocortical insufficiency and its inhibition by glucosteroids | Q34266546 |
| PHYSIOLOGIC STUDIES OF ANTIDIURETIC HORMONE BY ITS DIRECT MEASUREMENT IN HUMAN PLASMA | Q35569316 | ||
| Immunoassay of plasma vasopressin in man. | Q35980079 | ||
| Evolution of antidiuretic hormones and their functions | Q40046487 | ||
| Metabolism of antidiuretic hormones | Q40046509 | ||
| The regulation of antidiuretic hormone release in man: I. Effects of change in position and ambient temperature on blood ADH levels | Q40350554 | ||
| Radioimmunoassay of Vasopressin: Application to Unextracted Human Urine | Q43628163 | ||
| Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays† | Q46302797 | ||
| Radioimmunoassay of Vasopressin with a Comparison of Immunological and Biological Activity in the Rat Posterior Pituitary | Q49053434 | ||
| Binding properties of bovine neurophysins I and II: an equilibrium dialysis study | Q51108430 | ||
| Physiologic investigation of posterior pituitary binding proteins neurophysin I and neurophysin II | Q52996464 | ||
| Radioimmunoassay of arginine vasopressin in human plasma. | Q52999069 | ||
| Effect of +Gz and +Gx acceleration on peripheral venous ADH levels in humans | Q68403757 | ||
| Radioimmunoassay for plasma antidiuretic hormone | Q70452976 | ||
| Tentative Identification of Arginine Vasotocin in Human Cerebrospinal Fluid | Q71560288 | ||
| The development of a radioimmunoassay and a plasma extraction method for vasopressin | Q71575184 | ||
| Hyperuricemia, a concomitant of congenital vasopressin-resistant diabetes insipidus in the adult | Q71779604 | ||
| Antidiuretic hormone levels in normal subjects | Q71789551 | ||
| A Radioimmunoassay for Parathyroid Hormone in Man | Q72074277 | ||
| Antivasopressin antibody. Characterization of high-affinity rabbit antibody with limited association constant heterogeneity | Q72466554 | ||
| Immunochemical Studies with Lysine Vasopressin | Q72763815 | ||
| Specific antibody to vasopressin in man | Q72784627 | ||
| METHOD FOR THE ASSAY OF ANTIDIURETIC HORMONE IN PLASMA WITH A NOTE ON THE ANTIDIURETIC TITER OF HUMAN PLASMA | Q76539674 | ||
| Purification of oxytocin and vasopressin by way of a protein complex | Q78279267 | ||
| Radioimmunological system for the determination of the antidiuretic hormone | Q93801134 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | AVP | Q12009087 |
| P304 | page(s) | 2340-2352 | |
| P577 | publication date | 1973-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma | |
| Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma | |||
| P478 | volume | 52 |
| Q39825434 | 9 Ageing and endocrine function |
| Q28281380 | A Comparison of Plasma Vasopressin Measurements with a Standard Indirect Test in the Differential Diagnosis of Polyuria |
| Q22252541 | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction |
| Q73707270 | A case of transient diabetes insipidus associated with poisoning by a herbicide containing glufosinate |
| Q34260031 | A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis |
| Q72863543 | A new extraction of arginine vasopressin from blood: The use of octadecasilyl-silica |
| Q30982488 | A novel AVP gene mutation in a Turkish family with neurohypophyseal diabetes insipidus |
| Q71075958 | A patient with polyuria and hyponatremia |
| Q41718894 | Abnormal regulation of antidiuretic hormone in idiopathic edema |
| Q42256054 | Activity-dependent secretion of neuronal activity regulated pentraxin from vasopressin neurons into the systemic circulation |
| Q45031026 | Acute infectious pneumonia is accompanied by a latent vasopressin-dependent impairment of renal water excretion |
| Q93649263 | Adipsic hypernatremia in a patient with pseudotumor cerebri and the primary empty sella syndrome |
| Q70287459 | Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine |
| Q38736926 | Am I Drinking Enough? Yes, No, and Maybe |
| Q34337847 | Angiotensin stimulated AVP-release in humans |
| Q70981159 | Angiotensin stimulates oxytocin release |
| Q58164305 | Antidiuretic Hormone (ADH) and Endolymphatic Hydrops |
| Q39656090 | Antidiuretic hormone excess |
| Q70784655 | Antidiuretic hormone levels in stroke patients |
| Q24553312 | Antidiuretic hormone regulation in patients with primary nocturnal enuresis |
| Q26741093 | Arginine Vasopressin and Copeptin in Perinatology |
| Q51858392 | Arginine vasopressin response to anaesthesia produced by halothane, enflurane and isoflurane. |
| Q91861709 | Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study |
| Q30693052 | Association of HPA axis hormones with copeptin after psychological stress differs by sex |
| Q53603650 | Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD). |
| Q38059154 | Biomarkers in acute coronary artery disease |
| Q69754981 | Blood pressure and renal function in a novel vasopressin-deficient, genetically hypertensive rat strain |
| Q48394916 | Brain vasopressin levels in Down syndrome and Alzheimer's disease |
| Q48234943 | Caffeine intake enhances the benefits of sodium glucose transporter 2 inhibitor. |
| Q46000563 | Cardiovascular and arginine vasopressin (AVP) responses to haemorrhage and nitroprusside infusion in conscious newborn calves. |
| Q53848266 | Cardiovascular and hormonal responses to ANP infusion in the guinea-pig: effects of angiotensin-converting enzyme inhibition with perindopril |
| Q100736096 | Cellular dehydration acutely degrades mood mainly in women: a counterbalanced, crossover trial |
| Q31884952 | Central interactions between angiotensin II and PGD(2) in the regulation of vasopressin and oxytocin secretion in dehydrated rats |
| Q72501211 | Central neural peptides and catecholamines in spontaneous and DOCA/salt hypertension |
| Q28326748 | Central, renal and adrenal effects of lithium in man |
| Q70884386 | Cerebral neuronal activity in spontaneously hypertensive rats as demonstrated by the 14C-deoxyglucose method |
| Q34570889 | Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy |
| Q89520873 | Changing the diagnostic approach to diabetes insipidus: role of copeptin |
| Q41934900 | Chronic hypernatremia from a congenital defect in osmoregulation of thirst and vasopressin |
| Q37274293 | Chronic recurrent dehydration associated with periodic water intake exacerbates hypertension and promotes renal damage in male spontaneously hypertensive rats |
| Q69894427 | Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure |
| Q34248479 | Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension |
| Q57792237 | Clinical and hormonal conditions associated with sodium retention in cirrhotic patients with ascites |
| Q33710301 | Co-peptin: Role as a novel biomarker in clinical practice |
| Q39137960 | Comparative water metabolism of Barrow Island macropodid marsupials: hormonal versus behavioural-dependent mechanisms of body water conservation |
| Q45339678 | Comparison between blood and urinary indices for dehydration: a different interpretation |
| Q51049580 | Comparison of ex vivo stability of copeptin and vasopressin. |
| Q51564442 | Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. |
| Q34983634 | Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness |
| Q30867263 | Control of the renal medullary circulation by vasopressin V1 and V2 receptors in the rat. |
| Q36258947 | Copeptin Predicts Mortality in Critically Ill Patients |
| Q37508425 | Copeptin and its potential role in diagnosis and prognosis of various diseases |
| Q35561316 | Copeptin and risk stratification in patients with acute dyspnea |
| Q40447903 | Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis. |
| Q42435453 | Copeptin as a marker for arginine-vasopressin/antidiuretic hormone secretion in the diagnosis of paraneoplastic syndrome of inappropriate ADH secretion. |
| Q41537624 | Copeptin as a marker of an altered CRH axis in pituitary disease |
| Q34307867 | Copeptin as a marker of relative arginine vasopressin deficiency after pediatric cardiac surgery. |
| Q44878250 | Copeptin in acute chest pain: identification of acute coronary syndrome and obstructive coronary artery disease on coronary CT angiography |
| Q38705713 | Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. |
| Q35658585 | Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study |
| Q33670687 | Copeptin levels remain unchanged during the menstrual cycle |
| Q35556651 | Copeptin testing in acute myocardial infarction: ready for routine use? |
| Q51035312 | Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33). |
| Q38201385 | Dehydration: physiology, assessment, and performance effects |
| Q35989406 | Desmopressin: in adults with nocturia |
| Q53954956 | Development of a solid-phase radioimmunoassay for the determination of arginine-vasopressin in urine. |
| Q39806269 | Developmental Pharmacokinetics of the Posterior Pituitary Hormones |
| Q95570048 | Diabetes insipidus |
| Q41477060 | Diabetes insipidus: a physiologic approach to diagnosis |
| Q38612616 | Diagnostic approach to polydipsia and polyuria |
| Q48745946 | Different effects of chronic Na+, Cl-, and K+ depletion on brain vasopressin mRNA and plasma vasopressin in young rats |
| Q52964191 | Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. |
| Q59075830 | Direct inhibition of testicular androgen biosynthesis revealing antigonadal activity of neurohypophysial hormones |
| Q40335925 | Disorders of the endocrine system. |
| Q90632812 | Distinguishing Low and High Water Consumers-A Paradigm of Disease Risk |
| Q35200431 | Distribution, blood transport, and degradation of antidiuretic hormone in man |
| Q37914863 | E-series prostaglandins and arginine vasopressin in the modulation of male sexual behavior |
| Q67239483 | Effect of a test meal, duodenal acidification, and tetragastrin on the plasma concentration of β-endorphin-like immunoreactivity in man |
| Q70566888 | Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats |
| Q34549626 | Effect of arginine vasopressin on renal medullary blood flow. A videomicroscopic study in the rat |
| Q68877408 | Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension |
| Q41450493 | Effect of exercise on plasma concentrations of arginine vasopressin, angiotensin II and aldosterone in hypertensive and normotensive renal transplant recipients |
| Q47742757 | Effect of increased water intake on plasma copeptin in healthy adults |
| Q42249976 | Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension |
| Q48312888 | Effect of pre- and postnatal nicotine exposure on vasopressinergic system in rats |
| Q41682950 | Effect of saline infusion on plasma immunoreactive vasotocin in conscious chickens (Gallus domesticus) |
| Q93659406 | Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II, aldosterone and arginine vasopressin in essential hypertension |
| Q34449512 | Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide |
| Q44611607 | Effects of bile salts on plasma concentration of beta-endorphin-like immunoreactivity in men. |
| Q48496060 | Effects of central injection of kyotorphin and L-arginine on oxytocin and vasopressin release and blood pressure in conscious rats |
| Q43241151 | Effects of drugs on water metabolism |
| Q40508135 | Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure |
| Q42447815 | Elevations in plasma ADH levels during PEEP ventilation in the dog: mechanisms involved |
| Q67466568 | Endocrine and hemodynamic responses to dopamine infusion in the guinea-pig: Effects of ACE inhibition with perindopril |
| Q94565346 | Endocrinological Features of Hartsfield Syndrome in an Adult Patient With a Novel Mutation of FGFR1 |
| Q78947502 | Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease |
| Q71614479 | Enzyme immunoassay for arginine vasopressin |
| Q37008736 | Evidence for a Role of Opioid Peptides in the Release of Arginine Vasopressin in the Conscious Rat |
| Q43046121 | Excess diuresis and natriuresis during acute sleep deprivation in healthy adults |
| Q26744192 | G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention |
| Q51858611 | Haemodynamic and plasma vasopressin responses with high-dose fentanyl anaesthesia during aorto-coronary bypass operations. |
| Q33610679 | Haemodynamic changes caused by alteration of autonomic activity in patients with heart failure |
| Q71875954 | Hemodynamic, renal, and hormonal responses to lower body positive pressure in human subjects |
| Q72897163 | Hemorrhage in newborn lambs: effects on arterial blood pressure, ACTH, cortisol, and vasopressin |
| Q34700152 | Hereditary central diabetes insipidus: plasma levels of antidiuretic hormone in a family with a possible osmoreceptor defect |
| Q40526444 | Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy |
| Q45175388 | Hormonal control of renal water excretion |
| Q34564758 | Human platelet fraction arginine-vasopressin. Potential physiological role |
| Q83823841 | Hydration assessment using the cardiovascular response to standing |
| Q44525641 | Hyperprolactinemia influences renal function in man |
| Q38946238 | Hyponatraemia in the first week of life in preterm infants. Part I. Arginine vasopressin secretion |
| Q72477133 | Hyponatraemia: mechanisms and management |
| Q41484947 | Hyponatremia and hypernatremia |
| Q33938395 | Hyponatremia and hypernatremia. A systematic approach to causes and their correction |
| Q44553372 | Hyponatremia hypo-osmolarity in neurosurgical patients. “Appropriate secretion of ADH” and “Cerebral salt wasting syndrome” |
| Q61846582 | Hypopituitarism |
| Q42454698 | Hypothalamic catecholamine biosynthesis and pituitary gonadotropin secretion in vitro: Effect of hyperprolactinemia |
| Q34782796 | Iatrogenic hyponatraemia of the newborn due to maternal fluid overload: a prospective study. |
| Q35882453 | Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus |
| Q70775604 | Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue |
| Q48940367 | In vivo effect of cellular calcium uptake on osmotic and nonosmotic release of arginine vasopressin |
| Q66911720 | Inappropriate antidiuretic hormone secretion |
| Q71508716 | Inappropriate antidiuretic hormone secretion of unknown origin |
| Q67537925 | Inappropriate secretion of antidiuretic hormone in a premature infant |
| Q55397222 | Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS). |
| Q44922311 | Increased abdominal-to-peripheral fat distribution contributes to altered autonomic-circulatory control with human aging. |
| Q36654536 | Increased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans |
| Q41676202 | Individual neurophysin concentrations in the pituitary and circulation of humans |
| Q67004595 | Influence of the emetic reflex on vasopressin release in man |
| Q39676774 | Inhibition of gastrin secretion by hypertonic solutions in patients with pernicious anaemia and duodenal ulcer |
| Q39450440 | Inhibiton of Fc-rosette formation by serum of patients with renal allograft rejection |
| Q38111729 | Integrated physiological mechanisms of exercise performance, adaptation, and maladaptation to heat stress |
| Q43851021 | Interactions among challenges of hydromineral balance, angiotensin-converting enzyme, and cystine aminopeptidase. |
| Q34433896 | Intraoperative changes in blood pressure, heart rate, plasma vasopressin, and urinary noradrenalin during elective ovariohysterectomy in dogs: repeatability at removal of the 1st and 2nd ovary |
| Q57153205 | Iodination and purification of oxytocin |
| Q43961449 | Is autonomic support of arterial blood pressure related to habitual exercise status in healthy men? |
| Q39362674 | Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats? |
| Q39008229 | Kidney function and the role of arginine vasotocin in three agamid lizards from habitats of differing aridity in Western Australia |
| Q67255534 | Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: Relation to adenylate cyclase activation |
| Q52100583 | Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action |
| Q34081604 | Mechanism of diuretic response to increased left atrial pressure in the anesthetized dog |
| Q85096540 | Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy |
| Q68896516 | Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure |
| Q46849930 | Molecular analysis of impaired urinary diluting capacity in glucocorticoid deficiency. |
| Q47955891 | Morphological and functional changes in a new animal model of Ménière's disease |
| Q44760142 | NO inhibition of the magnocellular neuroendocrine system in rats is independent of cGMP signaling pathway |
| Q49135247 | Neurohypophyseal Dopamine Biosynthesis in the Spontaneously Hypertensive Rat |
| Q40205447 | Neurohypophyseal peptides in hypothyroid rats: Plasma levels and kidney response |
| Q48001144 | Nitric oxide control of drinking, vasopressin and oxytocin release and blood pressure in dehydrated rats |
| Q44000339 | Nitric oxide, interleukin and prostaglandin interactions affecting the magnocellular system |
| Q58118186 | Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment |
| Q41206746 | Normalization of plasma arginine vasopressin concentrations when children with meningitis are given maintenance plus replacement fluid therapy |
| Q58283497 | Novel and Sensitive Noncompetitive Enzyme Immunoassay (Hetero-Two-Site Enzyme Immunoassay) for Arginine Vasopressin |
| Q33907444 | Opioid antagonist diprenorphine microinjected into parabrachial nucleus selectively inhibits vasopressin response to hypovolemic stimuli in the rat. |
| Q48938162 | Osmolal effects on vasopressin secretion in the streptozotocin-diabetic rat. |
| Q37001520 | Osmoregulation during pregnancy in the rat. Evidence for resetting of the threshold for vasopressin secretion during gestation |
| Q49049804 | Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes |
| Q33540613 | Osmoregulation of vasopressin neurons: a synergy of intrinsic and synaptic processes |
| Q44653218 | Osmoregulation of vasopressin release and gene transcription under acute and chronic hypovolemia in rats |
| Q52740932 | Osmotic regulation of vasopressin in the cat. |
| Q44580063 | Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). |
| Q69940657 | Pharmacokinetic-hemodynamic interactions between vasopressin and nitroglycerin: comparison between intravenous and cutaneous routes of nitrate delivery |
| Q40064592 | Pituitary Morphology and Function in 43 Children with Central Diabetes Insipidus |
| Q67428468 | Plasma ADH in normal long-evans rats and in long-evans rats heterozygous and homozygous for hypothalamic diabetes insipidus |
| Q70800872 | Plasma Vasopressin Response to Hypertonic Saline Infusion to Assess Posterior Pituitary Function |
| Q83593818 | Plasma levels of copeptin in patients with coronary heart disease |
| Q67351707 | Plasma potassium and sodium appetite; the effect of potassium infusion in sheep |
| Q40962430 | Plasma vasopressin in ethanol intoxication and hangover |
| Q41456898 | Polyuria in Children: Clinical Evaluation and Differential Diagnosis |
| Q38776526 | Polyuric states in man. |
| Q30436805 | Postoperative care following pituitary surgery |
| Q35105428 | Postoperative endocrine management of pituitary tumors |
| Q70754277 | Postprandial release of neurotensin-like immunoreactivity and its mechanism |
| Q40305945 | Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. |
| Q37892306 | Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease |
| Q83242325 | Potential impact of a 500-mL water bolus and body mass on plasma osmolality dilution |
| Q41520470 | Predictive value of plasma copeptin level for the risk and mortality of heart failure: a meta-analysis |
| Q44043746 | Preparation of anti-vasopressin antibodies using an IgA carrier. Application to radioimmunoassay |
| Q67042000 | Production of porcine antibodies with high specificity to [8-D-arginine] deamino-vasopressin (dDAVP) |
| Q37573138 | Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis |
| Q71713132 | Radioimmunoassay of arginine-vasopressin in human plasma: development and clinical application |
| Q68811193 | Radioimmunoassay of urinary antidiuretic hormone in man: stimulation-suppression tests |
| Q70274642 | Radioimmunoassay of vasopressin in familial cental diabetes insipidus |
| Q51041122 | Rapid rule out of myocardial infarction with the use of copeptin as a biomarker for cardiac injury. |
| Q30999436 | Recurrent hypertonic dehydration due to selective defect in the osmoregulation of thirst |
| Q51587528 | Reference change values for monitoring dehydration. |
| Q39485902 | Regulation of plasma antidiuretic hormone in the dehydrated kangaroo rat (Dipodomys spectabilis M.) |
| Q36616057 | Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort |
| Q67833356 | Renin-aldosterone system and arginine vasopressin in diarrhoeic calves |
| Q55331707 | Resetting of osmoreceptor response as cause of hyponatraemia in acute idiopathic polyneuritis |
| Q43013458 | Response of novel biomarkers to BNP infusion in patients with decompensated heart failure: a multimarker paradigm |
| Q72809769 | Reversible vasopressin deficiency in severe hypernatremia |
| Q41600788 | Role of hepatic portal osmoreception in the control of ADH release |
| Q71217130 | Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat |
| Q34275916 | Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency |
| Q70950221 | Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis |
| Q71109034 | Role of vasopressin in support of blood pressure in potassium deficient rats |
| Q70734336 | Role of vasopressin in the impaired water excretion of glucocorticoid deficiency |
| Q34606923 | Role of volume in the regulation of vasopressin secretion during pregnancy in the rat |
| Q66972395 | Seasonal variations in vasopressin secretion in rats |
| Q48602181 | Selective chronic sodium or chloride depletion specifically modulates subfornical organ atrial natriuretic peptide receptor number in young rats |
| Q45952895 | Serial plasma vasopressin concentration in healthy and hospitalised neonatal foals. |
| Q68413419 | Serum vasopressin (AVP) levels in polyuric brain-dead organ donors |
| Q93683003 | Simple and rapid radioimmunoassay for the routine determination of vasopressin in plasma |
| Q70676995 | Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A 25 extraction |
| Q37043705 | Studies of the mechanism of contralateral polyuria after renal artery stenosis |
| Q41357705 | Sustained release verapamil in renal hypertension. |
| Q43809994 | Sweat tests in patients with diabetes insipidus |
| Q48006883 | Syndrome of inappropriate antidiuretic hormone secretion associated with acute myeloid leukemia with multilineage dysplasia |
| Q46938609 | Syndromes related to sodium and arginine vasopressin alterations in post-operative neurosurgery. |
| Q48400534 | Synergistic activation of rat supraoptic neurosecretory neurons by noxious and hypovolemic stimuli |
| Q43625085 | Synergistic interactions between footshocks and non-osmotic hypovolemia on vasopressin secretion in rats |
| Q34677232 | Systemic diseases associated with disorders of water homeostasis |
| Q40373207 | The Role of Blood Osmolality and Volume in Regulating Vasopressin Secretion in the Rat |
| Q34107759 | The clinical physiology of water metabolism. Part I: The physiologic regulation of arginine vasopressin secretion and thirst |
| Q48169068 | The correlation between plasma osmolarity and tear osmolarity |
| Q41062548 | The distribution of vasopressin-, oxytocin-, and neurophysin-producing neurons in the guinea pig brain. I. The classical hypothalamo-neurophypophyseal system |
| Q72655038 | The effect of abdominal pressure on plasma antidiuretic hormone levels in the dog |
| Q34051668 | The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unanaesthetized monkey (Macaca Mulatta) |
| Q40689012 | The handling of immunoreactive vasopressin by the isolated perfused rat kidney |
| Q42531619 | The influence of age on renal and extrarenal effects of frusemide |
| Q39661170 | The neurophysins in health and disease |
| Q40003212 | The osmoregulation of vasopressin |
| Q41196684 | The physiology of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders. |
| Q34538928 | The posterior pituitary and diabetes insipidus |
| Q33983062 | The posterior pituitary gland |
| Q33526184 | The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial |
| Q40746642 | The role of vasopressin and prolactin in abnormal salt and water metabolism of obese patients before and after fasting and during refeeding |
| Q43426486 | The syndrome of inappropriate antidiuretic hormone secretion as a cause of hyponatremia in cystic fibrosis |
| Q71951500 | The syndrome of inappropriate secretion of antidiuretic hormone |
| Q37891941 | The syndromes of primary hormone resistance |
| Q35458222 | The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia |
| Q70782533 | Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients |
| Q48754974 | Thirst and vasopressin secretion counteract dehydration in newborn infants |
| Q70276144 | Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors |
| Q26771172 | Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure |
| Q37710971 | Validation of an integrative mathematical model of dehydration and rehydration in virtual humans |
| Q36997178 | Vascular effects of arginine vasopressin during fluid deprivation in the rat. |
| Q68701960 | Vasopressin |
| Q26823378 | Vasopressin V1a and V1b receptors: from molecules to physiological systems |
| Q39661160 | Vasopressin and oxytocin in health and disease |
| Q39964611 | Vasopressin dependent adenylate cyclase in single segments of rabbit kidney tubule |
| Q36714235 | Vasopressin function in familial cranial diabetes insipidus |
| Q42786149 | Vasopressin receptor antagonists: the vaptans |
| Q51869921 | Vasopressin release by nicotine in the cat |
| Q47334957 | Vasopressin: physiology, assessment and osmosensation. |
| Q77867034 | Very delayed hyponatremia after surgery and radiotherapy for a pituitary macroadenoma |
| Q38776521 | Volume homeostasis and osmoregulation in human pregnancy |
| Q60916565 | Water Intake, Water Balance, and the Elusive Daily Water Requirement |
Search more.